Search results
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 52-Week High Following Analyst Upgrade
ETF DAILY NEWS· 9 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares reached a new 52-week high during mid-day trading on Monday after JPMorgan Chase ...
Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past...
Simply Wall St. via Yahoo Finance· 3 days agoBut on a lighter note, a good company can see its share price rise well over 100%. Long term ...
Regeneron director Brown sells shares worth over $1.5 million By Investing.com
Investing.com· 2 hours agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) Director Michael S. Brown has completed...
Teachers Retirement System of The State of Kentucky Sells 1,245 Shares of Regeneron Pharmaceuticals,...
ETF DAILY NEWS· 1 day agoTeachers Retirement System of The State of Kentucky cut its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% during the 4th ...
RBC lifts Regeneron stock PT to $1,229 on higher sales estimetes of Dupixent By Investing.com
Investing.com· 5 days agoOn Wednesday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) saw an increase in its price target to...
Insider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) CEO Sells 9,064 Shares of Stock
ETF DAILY NEWS· 4 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) CEO Leonard S. Schleifer sold 9,064 shares of the company’s stock in a transaction on Tuesday ...
Regeneron, Sanofi Get Expanded FDA OK for Kevzara in Polyarticular Juvenile Idiopathic Arthritis
Morningstar· 6 days agoBy Colin Kellaher Regeneron Pharmaceuticals and Sanofi have won expanded Food and Drug Administration approval of their arthritis drug Kevzara for certain ...
...Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN - ...
Benzinga· 2 days agoNEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ:REGN). Such investors are
Regeneron (REGN), SNY Win FDA Nod for Kevzara Label Expansion
Zacks via Yahoo Finance· 6 days agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced that the FDA has approved a...
Regeneron holds Buy rating and price target from TD Cowen By Investing.com
Investing.com· 3 days agoOn Friday, TD (TSX:TD) Cowen maintained a Buy rating on shares of Regeneron (NASDAQ:REGN)...